Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-28T01:43:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Publications section now states that publications are provided voluntarily by the person who enters information about the study and are about the results of the study. The revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-20T23:09:24.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the banner about potential delays due to government funding for the NIH Clinical Center; this is a non-substantive site maintenance update that does not impact the trial information.
    Difference
    0.2%
    Check dated 2025-11-13T17:10:53.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No core study content changed; only non-substantive formatting and layout updates were applied. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:47:48.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Updated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.
    Difference
    0.1%
    Check dated 2025-10-01T05:51:39.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Upgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.
    Difference
    0.1%
    Check dated 2025-09-30T03:47:32.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.